AlphaFold arrived as a technical moonshot that suddenly made protein structures feel like software rather than secrets of nature, and five years on it has rewired how laboratories plan experiments, ...

The most visible impact of AI seems to be in coding, but it could also be poised to disrupt other hard sciences.

A computational biology company that started in space tech is looking to change how biopharma finds disease targets by modeling how proteins behave.

While many businesses continue to seek AI’s killer app, biochemists have already found it. That application is protein folding. This week marks the five-year anniversary of the debut of Alpha Fold 2, ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More A trio of scientists consisting of Demis Hassabis, co-founder and CEO of ...

This is the third in a three-part series from Medscape on the impact of AI on drug discovery and development. Part 1 is about AI's role in designing speedier, more effective clinical trials. Part 2 is ...